Abstract: As multi-sensor technology advances and data storage and processing capabilities improve, multi-sensor signals can provide a more comprehensive and multi-angle data perspective. This ...
Abstract: Timely detection and accurate diagnosis of faults in technological processes can significantly reduce production costs in manufacturing. Modern industrial equipment, equipped with numerous ...
Anyone possessing an ageing mobile that's presently linked to the O2 network must upgrade immediately. The well-known British provider has just delivered a final alert, and disregarding it could ...
Hosted on MSN
Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its investigational CD19-CAR T cell therapy, resecabtagene autoleucel (rese-cel), during two ...
Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome, supporting a bullish outlook. KYTX's Miv-cel achieved significant clinical improvements and ...
WASHINGTON — A defense policy bill expected to be voted on this week does not include provisions that would have ensured the military’s ability to purchase the technical data, parts and information ...
93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell lymphoma in the 3L+ setting 83% overall response and 61% complete ...
– 96% Overall Response Rate, 74% Stringent Complete Response/Complete Response, and 95% Minimal Residual Disease Negativity Observed at a Median 15.9-months of Follow-up, with Responses Continuing to ...
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback